• Adtralza 150 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  TRALOKINUMAB	150 mg

  ATC: D11A D11AH D11AH07

• Adtralza 300 mg solution for injection in pre-filled pen

  Form: solution for injection

  Active substance	Dosage
  TRALOKINUMAB	300 mg

  ATC: D11A D11AH D11AH07

• Adventan 1 mg/g cream

  Form: cream

  Active substance	Dosage
  METHYLPREDNISOLONE ACEPONATE	0,1 g

  ATC: D07A D07AC D07AC14

• Adventan 1 mg/g cutaneous emulsion

  Form: emulsion, cutaneous

  Active substance	Dosage
  METHYLPREDNISOLONE ACEPONATE	100 mg

  ATC: D07A D07AC D07AC14

• Adventan 1 mg/g ointment

  Form: ointment

  Active substance	Dosage
  METHYLPREDNISOLONE ACEPONATE	0,1 g

  ATC: D07A D07AC D07AC14

• Adventan 1 mg/g ointment

  Form: ointment

  Active substance	Dosage
  METHYLPREDNISOLONE ACEPONATE	0,1 g

  ATC: D07A D07AC D07AC14

• Anzupgo 20 mg/g cream

  Form: cream

  Active substance	Dosage
  DELGOCITINIB	20 mg

  ATC: D11A D11AH D11AH11

• Claral 1 mg/g cream

  Form: cream

  Active substance	Dosage
  DIFLUCORTOLONE VALERATE	1,0 mg

  ATC: D07A D07AC D07AC06

• Daivobet 50 micrograms/0.5 mg/g gel

  Form: gel

  Active substance	Dosage
  CALCIPOTRIOL MONOHYDRATE	50 µg
  BETAMETHASONE DIPROPIONATE	0,5 mg

  ATC: D05A D05AX D05AX52

• Daivobet 50 micrograms/0.5 mg/g ointment

  Form: ointment

  Active substance	Dosage
  BETAMETHASONE DIPROPIONATE	0,5 mg
  CALCIPOTRIOL	50 µg

  ATC: D05A D05AX D05AX52

• Daivonex 50 micrograms/g cream

  Form: cream

  Active substance	Dosage
  CALCIPOTRIOL	50 µg

  ATC: D05A D05AX D05AX02

• Enstilar 50 micrograms/g + 0.5 mg/g cutaneous foam

  Form: foam, cutaneous

  Active substance	Dosage
  CALCIPOTRIOL MONOHYDRATE	50,0 µg
  BETAMETHASONE DIPROPIONATE	0,5 mg

  ATC: D05A D05AX D05AX52

• Finacea 150 mg/g gel

  Form: gel

  Active substance	Dosage
  AZELAIC ACID	15 g

  ATC: D10A D10AX D10AX03

• Fucibet Lipid 20 mg/g + 1 mg/g cream

  Form: cream

  Active substance	Dosage
  FUSIDIC ACID	20 mg/g
  BETAMETHASONE 17-VALERATE	1,214 mg/g

  ATC: D07C D07CC D07CC01

• Fucidine H, 20 mg/g + 10 mg/g cream

  Form: cream

  Active substance	Dosage
  FUSIDIC ACID	20 mg
  HYDROCORTISONE ACETATE	10 mg

  ATC: D07C D07CA D07CA01

• Innohep 10,000 UI anti-Xa/0.5 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	0,5 ml UI

  ATC: B01A B01AB B01AB10

• Innohep 12,000 IU anti-Xa/0.6 mL solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	20000 UI

  ATC: B01A B01AB B01AB10

• Innohep 14,000 IU anti-Xa/0.7 mL solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	20.000 UI

  ATC: B01A B01AB B01AB10

• Innohep 16,000 IU anti-Xa/0.8 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	20000 UI

  ATC: B01A B01AB B01AB10

• Innohep 18,000 IU anti-Xa/0.9 mL solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	20.000 UI

  ATC: B01A B01AB B01AB10

• Innohep 3,500 IU anti-Xa/0.35 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	10.000 UI

  ATC: B01A B01AB B01AB10

• Innohep 4,500 UI anti-Xa/0.45 ml solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	10.000 UI

  ATC: B01A B01AB B01AB10

• Innohep 8,000 IU anti-Xa/0.4 mL solution for injection in pre-filled syringes

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  TINZAPARIN SODIUM	20000 UI

  ATC: B01A B01AB B01AB10

• Kyndacel 210 mg solution for injection in pre-filled syringe

  Form: solution for injection

  Active substance	Dosage
  BRODALUMAB	210 mg

  ATC: L04A L04AC L04AC12

• Protamine sulfate Leo Pharma 1.400 IU anti-heparin (10 mg)/ml solution for injection and infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  PROTAMINE SULFATE	10 mg/ml

  ATC: V03A V03AB V03AB14

• Protopic 0.03% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,3 mg

  ATC: D11A D11AH D11AH01

• Protopic 0.03% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	0,3 mg

  ATC: D11A D11AH D11AH01

• Protopic 0.1% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1 mg

  ATC: D11A D11AH D11AH01

• Protopic 0.1% ointment

  Form: ointment

  Active substance	Dosage
  TACROLIMUS MONOHYDRATE	1 mg

  ATC: D11A D11AH D11AH01

• Spevigo 150 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ESPESOLIMAB	150 mg

  ATC: L04A L04AC L04AC22

• Spevigo 300 mg solution for injection in pre-filled syringe

  Form: solution for injection in a pre-filled syringe

  Active substance	Dosage
  ESPESOLIMAB	300 mg

  ATC: L04A L04AC L04AC22

• Spevigo 450 mg concentrate for infusion solution

  Form: solution for infusion, concentrate

  Active substance	Dosage
  ESPESOLIMAB	450 mg

  ATC: L04A L04AC L04AC22